Bunge (BG) Q3 2025 earnings review
Viterra Integration Drives Revenue Surge, But Flat Earnings and Weak Guidance Disappoint
Bunge's first full quarter integrating Viterra showed the massive scale of the new company, with revenue jumping 72% YoY to $22.2 billion. However, this top-line explosion did not translate to the bottom line, as Adjusted EPS remained flat YoY at $2.27. Strong execution in the core Soybean and Softseed processing segments, which benefited from the expanded global footprint, was offset by higher corporate and interest costs and a dilutive impact from the acquisition. The company maintained its full-year guidance, which implies a material sequential and YoY slowdown in Q4 earnings. A major red flag is the negative year-to-date operating cash flow of -$503M, a stark reversal from last year, driven by a significant working capital build post-merger.
🐂 Bull Case
The combination is creating a more balanced and resilient global platform. The core processing segments (Soybean & Softseed) showed strong performance, demonstrating the commercial benefits of the expanded footprint, particularly in South America and Europe.
Despite the costs of the acquisition, the company demonstrated confidence by repurchasing $545 million of its shares during the quarter, continuing its commitment to returning capital to shareholders.
🐻 Bear Case
A 72% increase in revenue yielding flat Adjusted EPS is underwhelming and points to margin compression or a dilutive impact from Viterra. Management confirmed on the call that Viterra is expected to be 'mildly dilutive' for the full year.
Maintained full-year guidance implies a Q4 Adjusted EPS of ~$1.86 at the midpoint, a significant sequential decline from Q3 and below the prior year's Q4, suggesting near-term headwinds are intensifying.
Operating cash flow was negative $503 million year-to-date versus a positive $847 million last year. This sharp reversal, driven by a large build in inventory and receivables post-merger, raises concerns about working capital management and integration efficiency.
⚖️ Verdict: 🔴
Bearish. The headline revenue growth masks a concerning lack of earnings leverage and a weak forward outlook. The flat year-over-year adjusted EPS post-acquisition is a disappointment, but the stark reversal to negative operating cash flow is a more significant red flag. Until Bunge can demonstrate profitable growth and normalize its cash conversion cycle, the integration risks and implied Q4 slowdown outweigh the benefits of the increased scale.
Key Themes
Negative Operating Cash Flow Flashes Warning Signal
For the first nine months of FY25, Bunge reported negative operating cash flow of -$503 million, a sharp reversal from the +$847 million generated in the same period last year. This occurred despite reporting positive Net Income of $721 million. Management attributed the drain to net changes in working capital, as inventories ballooned to $13.3 billion (from $6.5 billion at year-end) and receivables grew following the Viterra acquisition. This significant cash burn highlights potential integration challenges and inefficient working capital management in the combined entity.
Viterra Integration: All Volume, Muted EPS Accretion
The first full quarter with Viterra highlights the scale of the merger, with revenue up 72% and Adjusted Total EBIT up 54% YoY. However, Adjusted EPS was flat at $2.27 vs $2.29, indicating that higher interest expense, an increased share count, and integration costs fully absorbed the operational gains. On the call, management confirmed that Viterra is expected to be 'mildly dilutive' for the full year. This raises questions about the near-term financial benefits of the transformative deal.
Guidance Implies Q4 Slowdown
The company maintained its full-year adjusted EPS guidance of $7.30-$7.60. After a $2.27 result in Q3, this implies a Q4 range of just $1.73-$1.98. The midpoint of $1.86 represents a 18% sequential decline and a 13% YoY decline from Q4 2024. Management attributed the expected softness to policy uncertainty and customers operating on a spot basis, signaling that near-term market conditions are worsening.
Core Processing Strength Highlights Synergy Potential
The bright spot in the quarter was the performance of the newly combined processing segments. Soybean Processing & Refining Adjusted EBIT grew 67% YoY to $478M, while Softseed Processing & Refining jumped 107% to $275M. Management credited strong execution, higher margins, and the addition of Viterra's assets, particularly in South America and Europe, demonstrating the power of the expanded and more balanced global footprint.
Navigating Macro and Policy Uncertainty
Management continues to highlight a complex operating environment with 'macro trade and biofuel policy uncertainty.' This is causing both farmers and end customers to remain 'largely spot' in their transactions, reducing forward visibility and contributing to the cautious Q4 outlook. Global grain stocks-to-use ratios are elevated, dampening volatility and pressuring certain margins.
Other KPIs
The Viterra acquisition significantly increased Bunge's balance sheet size and leverage. Total debt more than doubled from $6.2B at year-end 2024 to $15.6B, while inventories also more than doubled to $13.3B. Consequently, the company's position shifted from having readily marketable inventories (RMI) exceed net debt to having net debt exceed RMI by approximately $900 million. The adjusted leverage ratio rose to 2.2x.
Effective this quarter, Bunge has realigned its reporting structure into four new segments: Soybean Processing & Refining, Softseed Processing & Refining, Other Oilseeds Processing & Refining, and Grain Merchandising & Milling. This change reflects the integration of Viterra and aligns reporting with the company's end-to-end value chain operating model, but it complicates direct historical comparisons to prior Agribusiness and Refined & Specialty Oils segments.
Guidance
Decelerating. The company maintained its guidance. The midpoint of $7.45 represents a 19% decline from FY2024's $9.19 and a 45% decline from the peak in FY2023, reflecting a continued normalization of the market environment from recent highs.
Decelerating. This implied guidance represents a significant slowdown from Q3's $2.27 result and the $2.13 reported in Q4 2024. Management expects a softer quarter in its core processing segments due to ongoing policy uncertainty and cautious customer behavior.
The guidance for capital expenditures has been increased significantly from the prior range of $1.5-$1.7 billion guided in Q1, reflecting the inclusion of Viterra's investment plans into the combined company's forecast.
Key Questions
Operating Cash Flow Normalization
Operating cash flow was negative $503 million year-to-date, a sharp contrast to net income. Can you break down the large working capital build between legacy Bunge and Viterra, and provide a timeline for when you expect cash flow from operations to normalize and turn positive?
Drivers of Q4 Slowdown
Your full-year guidance implies a material sequential and year-over-year earnings decline in Q4. Can you provide more specific drivers for this expected softness in the core processing segments beyond general 'policy uncertainty'?
Path to Viterra Accretion
Adjusted EPS was flat year-over-year despite a 72% revenue increase from the Viterra acquisition. Can you quantify the dilutive impact in the quarter and outline the specific operational or synergy milestones that will drive EPS accretion in 2026?